• Jill Brennan-Cook, Lindsay Rein, Andrew Kuykendall, Natasha Johnson, Amie Koch, Allison O Taylor, Christopher A Jones, and Thomas W Leblanc.
• Duke University School of Nursing, Durham, North Carolina, USA.
• J Palliat Med. 2024 Aug 20.

AbstractMyeloproliferative neoplasms (MPNs) are a group of rare chronic progressive blood cancers that vary widely in clinical presentation, yet all patients have a risk of disease progression and thrombotic complications. Diseases include primary myelofibrosis, polycythemia vera, and essential thrombocythemia. With current treatment approaches, most patients live a prolonged life, but many experience a complex of symptoms that negatively influence their functional status and quality of life. Although significant advances have been made in preventing arterial and venous complications while mitigating inflammatory processes, comprehensive palliative care can help address unmet complex physical and psychosocial needs on a long-term basis. This article, created by a multidisciplinary group of providers, offers an overview of MPNs so palliative care clinicians can better support patients with these hematologic cancers.

6 keywords...

hide…